home.social

#sirna — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #sirna, aggregated by home.social.

fetched live
  1. OliX Signs New Partnership With L’Oréal to Expand Nail Health Research

    Lee Dong-ki, CEO of Olix. Photo courtesy of Olix OliX (226950.KQ), a Korean RNA interference (RNAi) therapeutics company,…
    #France #FR #Europe #EU #L'Oréal #beautysciencepartnership #BOLDventurefund #Koreabiotech #l'oreal #nailhealthresearch #Olix #RNAiplatform #siRNA
    europesays.com/france/43001/

  2. The video 🎥 of the #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.
    🔗 av.tib.eu/media/71537
    #DrugDelivery #siRNA
    #BeilsteinTalks

  3. The video 🎥 of the #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.
    🔗 av.tib.eu/media/71537
    #DrugDelivery #siRNA
    #BeilsteinTalks

  4. The video 🎥 of the #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.
    🔗 av.tib.eu/media/71537
    #DrugDelivery #siRNA
    #BeilsteinTalks

  5. The video 🎥 of the #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.
    🔗 av.tib.eu/media/71537
    #DrugDelivery #siRNA
    #BeilsteinTalks

  6. The video 🎥 of the #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover.
    🔗 av.tib.eu/media/71537
    #DrugDelivery #siRNA
    #BeilsteinTalks

  7. Most genetic screens characterize host factors important for early stages of #viral #infection. This study uses a genome-scale #siRNA screen designed to uncover key pathways influencing early & late stages of #SARSCoV2 infection, including non-canonical NF-κB pathway @PLOSBiology plos.io/3ZX0fRe

  8. Most genetic screens characterize host factors important for early stages of #viral #infection. This study uses a genome-scale #siRNA screen designed to uncover key pathways influencing early & late stages of #SARSCoV2 infection, including non-canonical NF-κB pathway @PLOSBiology plos.io/3ZX0fRe

  9. Most genetic screens characterize host factors important for early stages of #viral #infection. This study uses a genome-scale #siRNA screen designed to uncover key pathways influencing early & late stages of #SARSCoV2 infection, including non-canonical NF-κB pathway @PLOSBiology plos.io/3ZX0fRe

  10. Most genetic screens characterize host factors important for early stages of #viral #infection. This study uses a genome-scale #siRNA screen designed to uncover key pathways influencing early & late stages of #SARSCoV2 infection, including non-canonical NF-κB pathway @PLOSBiology plos.io/3ZX0fRe

  11. Most genetic screens characterize host factors important for early stages of #viral #infection. This study uses a genome-scale #siRNA screen designed to uncover key pathways influencing early & late stages of #SARSCoV2 infection, including non-canonical NF-κB pathway @PLOSBiology plos.io/3ZX0fRe

  12. Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  
    Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval............
    #Bleedingdisorders #FDA #Fitusiran #Haemophilia #Hemophilia #Qfitlia #siRNA
    Umesh Prasad

    scientificeuropean.co.uk/medic

  13. Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  
    Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval............
    #Bleedingdisorders #FDA #Fitusiran #Haemophilia #Hemophilia #Qfitlia #siRNA
    Umesh Prasad

    scientificeuropean.co.uk/medic

  14. Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  
    Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval............
    #Bleedingdisorders #FDA #Fitusiran #Haemophilia #Hemophilia #Qfitlia #siRNA
    Umesh Prasad

    scientificeuropean.co.uk/medic

  15. Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  
    Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval............
    #Bleedingdisorders #FDA #Fitusiran #Haemophilia #Hemophilia #Qfitlia #siRNA
    Umesh Prasad

    scientificeuropean.co.uk/medic

  16. Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  
    Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval............
    #Bleedingdisorders #FDA #Fitusiran #Haemophilia #Hemophilia #Qfitlia #siRNA
    Umesh Prasad

    scientificeuropean.co.uk/medic

  17. Starting TOMORROW, 📅 Nov. 14, 2024, at 🕒 2:30 PM CET: "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Register for FREE 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  18. Starting TOMORROW, 📅 Nov. 14, 2024, at 🕒 2:30 PM CET: "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Register for FREE 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  19. Starting TOMORROW, 📅 Nov. 14, 2024, at 🕒 2:30 PM CET: "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Register for FREE 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  20. Starting TOMORROW, 📅 Nov. 14, 2024, at 🕒 2:30 PM CET: "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Register for FREE 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  21. Starting TOMORROW, 📅 Nov. 14, 2024, at 🕒 2:30 PM CET: "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Register for FREE 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  22. Join the online #BeilsteinTalk "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Participation is FREE! Just register: 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  23. Join the online #BeilsteinTalk "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Participation is FREE! Just register: 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  24. Join the online #BeilsteinTalk "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Participation is FREE! Just register: 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  25. Join the online #BeilsteinTalk "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Participation is FREE! Just register: 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  26. Join the online #BeilsteinTalk "Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich, on 📅 Nov. 14, 2024 🕒 2:30–3:30 PM CET.

    Participation is FREE! Just register: 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  27. Save the date: 📅 Nov. 14, 2024 🕒 2:30–3:30 pm CET

    Online #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich.

    Register for FREE! 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  28. Save the date: 📅 Nov. 14, 2024 🕒 2:30–3:30 pm CET

    Online #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich.

    Register for FREE! 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  29. Save the date: 📅 Nov. 14, 2024 🕒 2:30–3:30 pm CET

    Online #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich.

    Register for FREE! 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  30. Save the date: 📅 Nov. 14, 2024 🕒 2:30–3:30 pm CET

    Online #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich.

    Register for FREE! 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  31. Save the date: 📅 Nov. 14, 2024 🕒 2:30–3:30 pm CET

    Online #BeilsteinTalk “Computational approaches in improving spermine-based RNA #nanocarriers" with Olivia Merkel, Ludwig-Maximilians-Universität Munich.

    Register for FREE! 🔗 beilstein-institut.de/en/talks

    #DrugDelivery #siRNA
    #BeilsteinTalks

  32. #Oligonucleotides are a relatively new( #novel ) class of #drugs that can modulate #gene expression through various mechanisms like #RNA interference, degradation, or splice-modulation.

    This includes drugs like small interfering RNA (#siRNA), #microRNA (miRNA), and antisense oligonucleotides (ASOs).

    ispe.org/pharmaceutical-engine

    nature.com/articles/s41573-020

    Paper:

    nature.com/articles/s41573-020

  33. #Oligonucleotides are a relatively new( #novel ) class of #drugs that can modulate #gene expression through various mechanisms like #RNA interference, degradation, or splice-modulation.

    This includes drugs like small interfering RNA (#siRNA), #microRNA (miRNA), and antisense oligonucleotides (ASOs).

    ispe.org/pharmaceutical-engine

    nature.com/articles/s41573-020

    Paper:

    nature.com/articles/s41573-020

  34. #Oligonucleotides are a relatively new( #novel ) class of #drugs that can modulate #gene expression through various mechanisms like #RNA interference, degradation, or splice-modulation.

    This includes drugs like small interfering RNA (#siRNA), #microRNA (miRNA), and antisense oligonucleotides (ASOs).

    ispe.org/pharmaceutical-engine

    nature.com/articles/s41573-020

    Paper:

    nature.com/articles/s41573-020

  35. are a relatively new( ) class of that can modulate expression through various mechanisms like interference, degradation, or splice-modulation.

    This includes drugs like small interfering RNA (#siRNA), (miRNA), and antisense oligonucleotides (ASOs).

    ispe.org/pharmaceutical-engine

    nature.com/articles/s41573-020

    Paper:

    nature.com/articles/s41573-020

  36. #Oligonucleotides are a relatively new( #novel ) class of #drugs that can modulate #gene expression through various mechanisms like #RNA interference, degradation, or splice-modulation.

    This includes drugs like small interfering RNA (#siRNA), #microRNA (miRNA), and antisense oligonucleotides (ASOs).

    ispe.org/pharmaceutical-engine

    nature.com/articles/s41573-020

    Paper:

    nature.com/articles/s41573-020

  37. Goldman Sachs closes $650M fund aimed at biotechs-- Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments— FDA ends busy year with three drug rejections --bit.ly/w28kSd #goldmansachs #biobucks #sirna #nash #fda #funding #pharmanews #biotech #biopharma #biotechnology #cafepharma

  38. Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss-- 5 of the best paid biopharma CEOs --One dose of Lilly’s siRNA drug cuts Lp(a) for a year -- See more on our front page news bit.ly/w28kSd #novonordisk #wegovy #heartdisease #clinicaltrials #executivepay #pharmaceos #ceos #aha #elililly #sirna #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  39. We just put in a manuscript using #siRNA for knockdown. Knockdown verified with RT-PCR and Western blot. Saw a phenotype. Rescued it with ectopic expression of the knocked down protein. A reviewer required us to repeat the experiments using #CRISPR, and why we didn''t use crispr in the first place ?#thatsecondreviewer
    #academia #cellbiology
    A: Because we didn't need to, <expletive>.

  40. We just put in a manuscript using #siRNA for knockdown. Knockdown verified with RT-PCR and Western blot. Saw a phenotype. Rescued it with ectopic expression of the knocked down protein. A reviewer required us to repeat the experiments using #CRISPR, and why we didn''t use crispr in the first place ?#thatsecondreviewer
    #academia #cellbiology
    A: Because we didn't need to, <expletive>.

  41. We just put in a manuscript using #siRNA for knockdown. Knockdown verified with RT-PCR and Western blot. Saw a phenotype. Rescued it with ectopic expression of the knocked down protein. A reviewer required us to repeat the experiments using #CRISPR, and why we didn''t use crispr in the first place ?#thatsecondreviewer
    #academia #cellbiology
    A: Because we didn't need to, <expletive>.

  42. We just put in a manuscript using #siRNA for knockdown. Knockdown verified with RT-PCR and Western blot. Saw a phenotype. Rescued it with ectopic expression of the knocked down protein. A reviewer required us to repeat the experiments using #CRISPR, and why we didn''t use crispr in the first place ?#thatsecondreviewer
    #academia #cellbiology
    A: Because we didn't need to, <expletive>.

  43. Paper from our team about #siRNA and #COVID19. Already published last year, but maybe still relevant 😌🙂. A Computational Design of siRNA in SARS-CoV-2 Spike Glycoprotein Gene and Its Binding Capability toward mRNA journal.ugm.ac.id/ijc/article/

  44. Paper from our team about #siRNA and #COVID19. Already published last year, but maybe still relevant 😌🙂. A Computational Design of siRNA in SARS-CoV-2 Spike Glycoprotein Gene and Its Binding Capability toward mRNA journal.ugm.ac.id/ijc/article/